Regulus Therapeutics Inc. (RGLS)
1.27
0.04 (3.67%)
At close: Jan 15, 2025, 3:59 PM
1.31
3.05%
After-hours Jan 15, 2025, 06:42 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| PE Ratio | -0.81 | -0.74 | -0.99 | -3.09 | -0.83 | -0.17 | -1.09 | -1.45 | -8.04 | -12.48 | -15.23 | -2.97 | -0.14 | -0.07 |
| PS Ratio | n/a | n/a | n/a | 4.72 | 2.25 | 112.61 | 1.09K | 99.52 | 21.60 | 92.22 | 14.53 | 4.07 | 0.08 | 0.13 |
| PB Ratio | 1.15 | 0.63 | 0.50 | 1.81 | 0.77 | -1.39 | 2.22 | 2.12 | 3.61 | 5.36 | 3.04 | 0.83 | -0.03 | 0.13 |
| P/FCF Ratio | -0.89 | -0.81 | -1.12 | -3.76 | -0.77 | -0.19 | -1.32 | -2.05 | -8.74 | -17.37 | -9.75 | -5.1 | -0.07 | 0.11 |
| P/OCF Ratio | -0.91 | -0.82 | -1.14 | -3.77 | -0.78 | -0.19 | -1.33 | -2.09 | -8.99 | -17.9 | -10.04 | -5.93 | -0.07 | 0.09 |
| OCF/S Ratio | n/a | n/a | n/a | -1.25 | -2.9 | -601.01 | -816.29 | -47.64 | -2.4 | -5.15 | -1.45 | -0.69 | -1.09 | 1.43 |
| Debt / Equity Ratio | 0.11 | 0.19 | 0.13 | 0.18 | 0.73 | -2.83 | 0.56 | 0.35 | n/a | 0.18 | 0.12 | 0.16 | -0.26 | 1.40 |
| Quick Ratio | 2.96 | 3.78 | 12.48 | 2.89 | 1.69 | 0.57 | 1.90 | 5.96 | 12.61 | 18.96 | 21.39 | 7.75 | 3.01 | 3.75 |
| Current Ratio | 3.31 | 3.78 | 12.48 | 3.17 | 1.87 | 0.72 | 2.05 | 6.37 | 11.74 | 18.96 | 21.38 | 7.75 | 3.01 | 3.75 |
| Asset Turnover | n/a | n/a | n/a | 0.27 | 0.16 | 0.00 | 0.00 | 0.01 | 0.15 | 0.04 | 0.16 | 0.12 | 0.32 | 0.14 |
| Interest Coverage | -51.5 | -41.05 | -32.53 | -7.83 | -7.9 | -19.96 | -25.76 | -68.95 | -1.05K | -1.15K | -494.5 | -50.91 | -18.39 | -42.81 |
| Return on Equity (ROE) | -1.42 | -0.85 | -0.51 | -0.59 | -0.93 | 8.32 | -2.04 | -1.46 | -0.45 | -0.43 | -0.2 | -0.28 | 0.18 | -1.95 |
| Return on Assets (ROA) | -0.98 | -0.61 | -0.41 | -0.41 | -0.44 | -1.74 | -0.92 | -0.81 | -0.4 | -0.33 | -0.15 | -0.17 | -0.18 | -0.26 |
| Return on Capital (ROIC) | -1.4 | -0.81 | -0.44 | -0.54 | -0.82 | -36.51 | -1.55 | -0.94 | -0.42 | -0.28 | -0.15 | -0.14 | -0.24 | -0.34 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | 99.85% | 99.82% | -47.09K% | -75.72K% | -5.29K% | -171.63% | -435.22% | -53.01% | 99.84% | 100.00% | 100.00% |
| Net Profit Margin | n/a | n/a | n/a | -152.54% | -272.13% | -67.65K% | -99.87K% | -6.85K% | -268.55% | -739.08% | -95.4% | -137.07% | -55.13% | -180.9% |
| Pretax Profit Margin | n/a | n/a | n/a | -157.21% | -272.12% | -67.57K% | -100.14K% | -6.85K% | -268.64% | -739.07% | -95.51% | -137.15% | -53.64% | -181.25% |
| Operating Profit Margin | n/a | n/a | n/a | -141.47% | -246.4% | -64.95K% | -97.40K% | -6.83K% | -263.78% | -585.6% | -90.97% | -99.01% | -51.76% | -180.19% |
| FCF Margin | n/a | n/a | n/a | -125.39% | -293.69% | -60.13K% | -82.07K% | -4.84K% | -247.07% | -530.98% | -149.04% | -79.9% | -113.58% | 115.01% |
| EBITDA Margin | n/a | n/a | n/a | -134.47% | -227.3% | -61.17K% | -92.85K% | -6.56K% | -260.72% | -719.13% | -88.38% | -127.2% | -44.22% | -171.29% |